Study to evaluate the efficacy of Sucralfate as a healing agent in bed sores.

A prospective, open label, pilot study to evaluate the role of Sucralfate in the management of pressure ulcers.

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2016/03/006745

Enrollment

Registered

2016-03-21

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Pressure Ulcer

Interventions

Intervention1: Sucralfate Ointment(7%): Dose: 20g of 7% Sucralfate ointment( i.e 1.4g Sucralfate) once daily for 14 days. Route: To be applied topically by gauze dressing. Control Intervention1: Norma

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with Grade 3 pressure ulcer as per NPUAP guidelines. 2. Patients aged between 18-60 years, both male & female, any ethnicity. 3. Patients who are able to give valid consent.

Exclusion criteria

Exclusion criteria: 1. Wounds with necrotic tissue. 2. Patients with anemia. (Hb 3. Patients with hypoalbuminemia. (albumin 4. Patient with any known renal disease will be excluded. 5. H/O diabetes, connective tissue disorder, malignancy,psychiatric disorder and any other major systemic illness.

Design outcomes

Primary

Measure	Time frame
Reduction in PUSH scores, decrease in surface area and decrease in volume of the ulcer.Timepoint: Day 0, Day 7, Day 14	—

Secondary

Measure	Time frame
To check for blood Aluminium levels in four (randomly chosen) patients from each group.Timepoint: Day 14	—

Countries

India

Contacts

Public ContactPrashanth H Chalageri

Christian Medical College, Vellore

jayanta.iamhere@gmail.com08017067178

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026